Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 2
2013 1
2014 1
2015 2
2016 4
2019 1
2020 1
2021 1
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
King B, Ohyama M, Kwon O, Zlotogorski A, Ko J, Mesinkovska NA, Hordinsky M, Dutronc Y, Wu WS, McCollam J, Chiasserini C, Yu G, Stanley S, Holzwarth K, DeLozier AM, Sinclair R; BRAVE-AA Investigators. King B, et al. N Engl J Med. 2022 May 5;386(18):1687-1699. doi: 10.1056/NEJMoa2110343. Epub 2022 Mar 26. N Engl J Med. 2022. PMID: 35334197 Clinical Trial.
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial.
Blauvelt A, Papp K, Gottlieb A, Jarell A, Reich K, Maari C, Gordon KB, Ferris LK, Langley RG, Tada Y, Lima RG, Elmaraghy H, Gallo G, Renda L, Park SY, Burge R, Bagel J; IXORA-R Study Group. Blauvelt A, et al. Br J Dermatol. 2020 Jun;182(6):1348-1358. doi: 10.1111/bjd.18851. Epub 2020 Jan 15. Br J Dermatol. 2020. PMID: 31887225 Free PMC article. Clinical Trial.
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial.
Paller AS, Seyger MMB, Magariños GA, Pinter A, Cather JC, Rodriguez-Capriles C, Zhu D, Somani N, Garrelts A, Papp KA; IXORA-PEDS Investigators. Paller AS, et al. JAMA Dermatol. 2022 May 1;158(5):533-541. doi: 10.1001/jamadermatol.2022.0655. JAMA Dermatol. 2022. PMID: 35416908 Free PMC article. Clinical Trial.
Erythematous Plaque in the Cheek of an HIV Patient.
Mercado R, González-Chávez J, Sánchez JL, Figueroa LD. Mercado R, et al. Among authors: gonzalez chavez j. Am J Dermatopathol. 2016 Jul;38(7):561. doi: 10.1097/DAD.0000000000000308. Am J Dermatopathol. 2016. PMID: 27322791 No abstract available.
Erythematous Plaque in the Cheek of an HIV Patient.
Mercado R, González-Chávez J, Sánchez JL, Figueroa LD. Mercado R, et al. Among authors: gonzalez chavez j. Am J Dermatopathol. 2016 Jul;38(7):531-2. doi: 10.1097/DAD.0000000000000309. Am J Dermatopathol. 2016. PMID: 26885601 No abstract available.
Use of allopathic and complementary medicine for preventing SARS-CoV-2 infection in Mexican adults: A national survey.
Ruiz-Padilla AJ, Alonso-Castro AJ, Preciado-Puga M, González-Núñez AI, González-Chávez JL, Ruiz-Noa Y, Ortiz-Cortes M, Brennan-Bourdon LM, Deveze-Álvarez MA. Ruiz-Padilla AJ, et al. Among authors: gonzalez chavez jl. Saudi Pharm J. 2021 Sep;29(9):1056-1060. doi: 10.1016/j.jsps.2021.07.009. Epub 2021 Jul 15. Saudi Pharm J. 2021. PMID: 34305423 Free PMC article.
18 results